Ken Griffin Amyris, Inc. Call Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$0.58 - $1.3 $79,344 - $177,840	-136,800 Reduced 19.46%	566,300 $583,000
Q1 2023 May 15, 2023	SELL	$1.09 - $1.82 $274,135 - $457,730	-251,500 Reduced 26.35%	703,100 $956,000
Q4 2022 Feb 14, 2023	BUY	$1.52 - $3.39 $791,920 - $1.77 Million	521,000 Added 120.16%	954,600 $1.46 Million
Q3 2022 Nov 14, 2022	BUY	$1.7 - $4.05 $474,810 - $1.13 Million	279,300 Added 181.01%	433,600 $1.27 Million

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.